New York – September 19, 2026 -- DarioHealth Corp. (NASDAQ: DRIO) has secured a new contract with one of New Jersey's largest health plans, covering approximately 1.5 million lives, through its channel partnership with Amwell. The program covering Dario's cardiometabolic suite and provider-backed care is expected to launch and begin generating revenue in the first quarter of 2027.
Amwell channel delivers third major state health plan in 12 months
The New Jersey deal follows previously secured contracts with major health insurers in Arizona and Florida, marking the third large state health plan Dario has signed through Amwell within the past year. The customer operates as an administrative services only (ASO) health plan, giving Dario access to a broad population of self-funded employer groups eligible to deploy its cardiometabolic solutions.
CEO cites scale as validation of channel distribution strategy
"This is exactly the type of scale we envisioned when we built our channel strategy," said Erez Raphael, Chief Executive Officer of Dario. He noted that the agreement combines the company's multi-condition platform, provider-backed care capabilities and DarioIQ's personalized engagement tools within a single employer relationship.
Platform spans five chronic condition categories under one contract
Dario's integrated offering addresses diabetes, hypertension, weight management, musculoskeletal and behavioral health needs through a single platform. The company has also extended its capabilities to include provider-backed clinical care, adding provider-led treatment to its existing digital engagement and chronic condition management tools.
Deal reduces reliance on direct-sales model
The addition of 1.5 million covered lives through the New Jersey plan demonstrates the capacity of channel partners to connect Dario with large payer populations without relying on traditional direct sales. The agreement expands Dario's relationship with Amwell as a distribution channel following the Arizona and Florida contracts.